Inc. (NASDAQ: COCH), a small-cap medical device company with a market capitalization of $29.4 million specializing in hearing loss solutions, has announced the expansion of its patent portfolio with ...

Shareholder distributions are appropriate. Capital intensity of the industry remains low and gross margins high. In addition, Cochlear enjoys high cash conversion, enabling it to typically pay out 70% ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cochlear Limited (CHEOF – Research Report) ...

Q2 2025 Management View CEO Dig Howitt highlighted a 6% increase in net sales on a constant currency basis, driven by 13% growth in Cochlear implant revenue and 22% growth in Acoustics revenue.

Cochlear shares were on track for their worst session in five years on Friday, after the Australian hearing implants maker reported first-half profit below estimates and forecast annual earnings at ...